mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.008 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.008 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.008 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.009 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.009 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |